Open forum infectious diseases Ogbuagu Onyema, Goldman Jason D, Gottlieb Robert L, Singh Upinder, Shinkai Masaharu, Acloque Gerard, Fusco Dahlene, Gonzalez Erika, Kumar Princy N, Koullias Yiannis, Luetkemeyer Annie, Lichtman Amos, Mozaffarian Afsaneh, Hyland Robert H, Humeniuk Rita, Llewellyn Joe, Osinusi Anu, Duff Frank, Caro Luzelena, Etchevers Kim, Davies Santosh, Hedskog Charlotte, Chen Shuguang, Nadig Priyanka, Kohli Anita, P-2036. Obeldesivir for Treatment of COVID-19 in Adults and Adolescents Without Risk Factors for Progression to Severe Disease: the OAKTREE Study 12:Suppl 1 2025
Journal of the Pediatric Infectious Diseases Society Norton Thomas D, Roque-Guerrero Lilia, Ali Shazia, Turner Kenneth C, Hamilton Jennifer D, Thakur Mazhar, Ganguly Samit, Atmodjo Dominique, Hooper Andrea T, Hussein Mohamed, Subramaniam Danise, Chao Jesse, Waldron Alpana, Xiao Jing, Davis John D, Hughes Diana, Irvin Susan C, Pan Cynthia, Mylonakis Eleftherios, Geba Gregory P, Cox Edward, Kohli Anita, Herman Gary A, Braunstein Ned, Dakin Paula, Kowal Bari, Bhore Rafia, DiCioccio A Thomas, , Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS+IMD) in Pediatric Outpatients With COVID-19 2024
Journal of hepatology Dale Kelly, Kohli Anita, Nadeem Rida, Alkhouri Naim, WED-151 Routine cholestasis genetic testing in patients with intrahepatic cholestasis of pregnancy reveals high prevalence of genetic variants of bile acid transport defects 80, p. S709 - S710 2024
Journal of hepatology Yuen Man-Fung, Heo Jeong, Nahass Ronald G., Wong Grace Lai-Hung, Burda Tatiana, Bhamidimarri Kalyan Ram, Hu Tsung-Hui, Nguyen Tuan T., Chen Chi-Yi, Gordon Stuart C., Holmes Jacinta, Chuang Wan-Long, Kohli Anita, Alkhouri Naim, Lim Young-Suk, Eley Timothy, Gray Kevin, Thi Emily P., Medvedeva Elina, Ganchua Sharie C., Iott Christina, Eill Elizabeth, Espiritu Christine L., Sims Karen D., Anderson Mark, Fortney Tiffany, Cloherty Gavin, WED-371 Imdusiran (AB-729) administered every 8 weeks in combination with 24 weeks of pegylated interferon alfa-2a in virally suppressed, HBeAg-negative subjects with chronic HBV infection leads to HBsAg loss in some subjects at end of IFN treatment 80, p. S809 - S810 2024
The American journal of gastroenterology Leff Phillip, Rida Nadeem, Dinner Brett, Ria Kundu, Naim Alkhouri, Kohli Anita, S3496 A Rare Case of Non-Cirrhotic Portal Hypertension Caused by Necrobiotic Xanthogranuloma 118:10S, p. S2296 - S2296 2023
Open forum infectious diseases Shapiro Adrienne E, Acloque Jude, Free Almena, Gonzalez-Rojas Yaneicy, Hussain Rubaba, Juarez Erick, Moya Jaynier, Parikh Naval, Pang Phillip S, Hong David K, Sager Jennifer E, Yeh Wendy W, Alexander Elizabeth L, Nader Ahmed, Gaffney Leah A, Kohli Anita, Inman David, Cebrik Deborah, Noormohamed Nadia, Wang Qianwen, Skingsley Andrew, Parra Sergio, Austin Daren, Peppercorn Amanda, Agostini Maria L, Chow Sophia, Mogalian Erik, Sarkis Elias, Intramuscular Versus Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Non-inferiority Clinical Trial 2023
Journal of hepatology Yuen Man-Fung, Heo Jeong, Nahass Ronald G, Wong Grace Lai-Hung, Burda Tatiana, Bhamidimarri Kalyan Ram, Nguyen Tuan, Lim Young-Suk, Medvedeva Elina, Hu Tsung-Hui, Chen Chi-Yi, Gordon Stuart C, Holmes Jacinta, Chuang Wan-Long, Kohli Anita, Alkhouri Naim, Gray Kevin, Thi Emily P., Eley Timothy, Sims Karen, LBP-38 - Preliminary safety and antiviral activity of AB-729 combination treatment with pegylated interferon alfa-2a in virally suppressed, HBeAg-negative subjects with chronic HBV infection 78, p. S125 - S125 2023
Journal of hepatology Alkhouri Naim, Topete Jesus, McCallum Meaghan, Blessing Kelly, Noureddin Mazen, Coste Angie, Kohli Anita, FRI-525 - The effects of a novel online app (Noom Weight) on weight loss and liver biomarkers in patients with NAFLD: a single arm proof-of-concept study 78, p. S828 - S828 2023
Journal of hepatology Alkhouri Naim, Leff Phillip, Nadeem Rida, Kohli Anita, Munteanu Mona, SAT-488 - LIVERFASt GP+ (GP+), a non-invasive blood testing for NAFLD staging, improves risk stratification of patients with indeterminate FIB-4 results 78, p. S711 - S711 2023
Hepatology communications Noureddin Mazen, Mena Edward, Vuppalanchi Raj, Samala Niharika, Wong Micaela, Pacheco Fabiana, Polanco Prido, Sakkal Celine, Antaramian Ani, Chang Devon, Noureddin Nabil, Alkhouri Naim, Kohli Anita, Harrison Stephen A. A., Gwarieh Samer, Truong Emily, Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+and 4 scores 7:5 2023
Hepatology (Baltimore, Md.) Chang Devon, Guindi Maha, Mena Edward A, Pacheco Fabiana, Wong Micaela, Todo Tsuyoshi T, Noureddin Mazen, Harrison Stephen, Noureddin Nabil, Ayoub Walid, Yang Ju Dong, Truong Emily, Kim Irene K, Kohli Anita, Alkhouri Naim, Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis 77:2, p. 546 - 557 2023
Clinical gastroenterology and hepatology Lawitz Eric J., Ruane Peter J., Kohli Anita, Harting Eliza, Ding Dora, Chuang Jen-Chieh, Huss Ryan S., Chung Chuhan, Myers Robert P., Loomba Rohit, Bhandari Bal Raj, Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat 21:1, p. 143 - 152.e3 2023
Journal of hepatology Alkhouri Naim, Herring Robert, Kabler Heidi, Kayali Zeid, Hassanein Tarek, Kohli Anita, Huss Ryan S., Zhu Yanni, Billin Andrew N., Balendran Clare, Damgaard Lars Holm, Buchholtz Kristine, Kjaer Mette Skalshoi, Myers Robert P., Loomba Rohit, Noureddin Mazen, Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial 77:3, p. 607 - 618 2022
Journal of hepatology Noureddin Mazen, Kohli Anita, Sheikh Aasim, Neff Guy, Bhandari Bal Raj, Gunn Nadege, Caldwell Stephen, Goodman Zachary, Huss Ryan, Ma Lily, Ding Dora, Chuang Jay, Poulos John, Chung Chuhan, Myers Robert, Patel Keyur, Borg Brian, Ghalib Reem, Iyer Rajalakshmi, Younes Ziad H., Elkhashab Magdy, Hassanein Tarek, Ruane Peter, Shiffman Mitchell, Strasser Simone, Wong Vincent Wai-Sun, Loomba Rohit, Alkhouri Naim, Kowdley Kris V., The MRI and AST (MAST) score is correlated with noninvasive and histologic markers of fibrosis in patients with advanced fibrosis due to NASH 77, p. S427 2022
The lancet. Gastroenterology & hepatology Harrison Stephen A., Leibowitz Mark, Khazanchi Arun, Sheikh Muhammad Y., Guy Cynthia D., Abdelmalek Manal F., Neff Guy, Gunn Nadege, Alkhouri Naim, Younes Ziad H., Bashir Mustafa R., Freilich Bradley, Kohli Anita, Rinella Mary E., Siddiqui Mohammad S., Kipnes Mark, Moussa Sam E., Bansal Meena, Baum Seth J., Thuluvath Paul J., Ling Lei, Lieu Hsiao D., Borg Brian, Ruane Peter J., Gottwald Mildred, Chang William, Khan Mujib, Chen Charles, Melchor-Khan Liza, DePaoli Alex M., Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial 7:7, p. 603 - 616 2022
Gastroenterology (New York, N.Y. 1943) Leff Phillip, Polanco Prido, Chatha Yash, Garg Pranay, Lantz Kimber A., Raman Aria, Gupta Jia, Kahlon Nikhil S., Choudhri Sahil, Kohli Anita, Alkhouri Naim, Tu1311: EXTERNAL VALIDATION OF THE AGILE3+ SCORE AS A PREDICTOR OF ADVANCED FIBROSIS IN A COHORT OF U.S. ADULTS WITH BIOPSYPROVEN NAFLD 162:7, p. S-1271 2022
The American journal of gastroenterology Harrison Stephen A., Baum Seth J., Gunn Nadege T., Younes Ziad H., Kohli Anita, Patil Rashmee, Koziel Margaret J., Chakravarthy Manu V., Zhao Jeff, Chera Harinder, Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease 116:12, p. 2399 - 2409 2021
Nature communications Harrison Stephen A., Gunn Nadege, Neff Guy W., Kohli Anita, Liu Liping, Flyer Abbey, Goldkind Lawrence, Di Bisceglie Adrian M., A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes 12:1, p. 5503 - 5503 2021
American journal of preventive cardiology Baum Seth J., Chakravarthy Manu V., Koziel Margaret J., Harrison Stephen A., Gunn Nadege T., Younes Ziad H., Kohli Anita, Zhao Jeff, Patil Rashmee, Fras Juan P., Hamill Michael, Daou Nadine, LIVRQNac (AXA1125) ENHANCES INSULIN SENSITIVITY IN PRIMARY HUMAN HEPATOCYTES AND IN SUBJECTS WITH NAFLD AND T2D 7, p. 100263 2021
Hepatology communications Younossi Zobair M., Stepanova Maria, Noureddin Mazen, Kowdley Kris V., Strasser Simone I., Kohli Anita, Ruane Peter, Shiffman Mitchell L., Huss Ryan S., Sheikh Aasim, Gunn Nadege, Caldwell Stephen H., Myers Robert P., Wai-Sun Wong Vincent, Loomba Rohit, Alkhouri Naim, Goodman Zachary, Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis 5:7, p. 1201 - 1211 2021
Diabetes (New York, N.Y.) Baum SETH, Frias JUAN P., Hamill MICHAEL, Daou NADINE, Zhao JEFF, Chakravarthy MANU, Koziel MARGARET, Harrison STEPHEN A., Gunn NADEGE T., Younes ZIAD, Kohli ANITA, Patil RASHMEE, 752-P: LIVRQNac (AXA1125) Enhances Insulin Sensitivity in Primary Human Hepatocytes and in Subjects with NAFLD and T2D 70:Supplement_1 2021
Hepatology (Baltimore, Md.) Loomba Rohit, Sheikh Aasim, Neff Guy, Bhandari Bal Raj, Gunn Nadege, Iyer Rajalakshmi, Ruane Peter, Shiffman Mitchell L., Strasser Simone, Wong Vincent Wai-Sun, Huss Ryan S., Ding Dora, Jia Catherine, Chuang Jen-Chieh, Chung Chuhan, Borg Brian B., Subramanian G. Mani, Myers Robert P., Patel Keyur, Ghalib Reem, Elkhashab Magdy, Kabler Heidi, Poulos John, Younes Ziad, Hassanein Tarek, Resnick Murray, Caldwell Stephen H., Goodman Zachary, Wapinski Ilan, Beck Andrew H., Kohli Anita, Noureddin Mazen, Kowdley Kris V., Alkhouri Naim, , Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH 73:2, p. 625 - 643 2021
Gastroenterology (New York, N.Y. 1943) Harrison Stephen A., Frias Juan P., Younes Ziad, Trotter James F., Gunn Nadege T., Moussa Sam E., Kohli Anita, Nelson Kristin, Bashir Mustafa R., Neff Guy, Guy Cynthia D., Paredes Angelo H., Lieu Hsiao D., Gottwald Mildred, Chang William C.G., Yan Andrew Z., DePaoli Alex M., Ling Lei, Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis 160:1, p. 219 - 231.e1 2021
Hepatology (Baltimore, Md.) Alkhouri Naim, Kohli Anita, Loomba Rohit, Harrison Stephen A, Maintaining Patient Safety and Data Integrity of Nonalcoholic Steatohepatitis Clinical Trials During the Severe Acute Respiratory Syndrome-Coronavirus 2 Pandemic 72:5, p. 1509 - 1513 2020
The American journal of gastroenterology Aggarwal Pankaj, Alkhouri Naim, Noureddin Mazen, Harrington Allison, Singh Tamneet, Cummings-John Oladuni, Kohli Anita, S1025 The Effects of Age on the Accuracy of the FAST Score to Predict the Presence of NASH With Significant Fibrosis 115:1, p. S522 - S522 2020
The American journal of gastroenterology Aggarwal Pankaj, Singh Tamneet, Cummings-John Oladuni, Kohli Anita, Noureddin Mazen, Harrington Allison, Alkhouri Naim, S1024 Evaluation of the FAST Score in Patients With Nonalcoholic Fatty Liver Disease and High Liver Stiffness Measurements 115:1, p. S522 - S522 2020
The American journal of gastroenterology Aggarwal Pankaj, Harrington Allison, Singh Tamneet, Cummings-John Oladuni, Kohli Anita, Noureddin Mazen, Alkhouri Naim, S3286 Identifying Patients With Metabolic Syndrome Who Require Pharmacotherapy for Nonalcoholic Steatohepatitis (NASH) Using the FAST Score 115:1, p. S1715 - S1715 2020
The American journal of gastroenterology Aggarwal Pankaj, Singh Tamneet, Harrington Allison, Cummings-John Oladuni, Kohli Anita, Noureddin Mazen, Alkhouri Naim, S1190 Identifying Patients With Type 2 Diabetes Mellitus Who Require Pharmacotherapy for Nonalcoholic Steatohepatitis (NASH) Using the FAST Score 115:1, p. S595 - S595 2020
Journal of hepatology Harrison Stephen A., Younes Ziad H., Trotter James F., Gunn Nadege T., Moussa Sam, Kohli Anita, Nelson Kristen, Gottwald Mildred, Chang William, Yan Andrew, Depaoli Alex, Ling Lei, Lieu Hsiao, Bashir Mustafa, Neff Guy, Guy Cynthia, Paredes Angelo, Frias Juan, LBO01 - Positive topline results from a 24-week, randomized, double-blind, placebo-controlled, multicenter, phase 2 study of the FGF19 analogue aldafermin (NGM282) in patients with non-alcoholic steatohepatitis 73, p. S114 - S115 2020
Journal of hepatology Harrison Stephen A., Patil Rashmee, Koziel Margaret J., Chera Harinder, Zhao Jeff, Chakravarthy Manu V., Kohli Anita, Baum Seth J., Gunn Nadege T., Younes Ziad H., LBP01 - Multifactorial effects of AXA1125 and AXA1957 observed on markers of metabolism, inflammation and fibrosis: a 16-week randomized placebo-controlled study in subjects with non-alcoholic fatty liver disease (NAFLD) with and without type 2 diabetes ( 73, p. S123 - S123 2020
Journal of hepatology Loomba Rohit, Noureddin Mazen, Kowdley Kris, Kohli Anita, Sheikh Aasim, Neff Guy, Bhandari Bal Raj, Gunn Nadege T., Caldwell Stephen, Goodman Zachary, Ding Dora, Wapinski Ilan, Resnick Murray, Beck Andrew, Jia Catherine, Huss Ryan, Chung Chuhan, Subramanian Mani, Ghalib Reem, Myers Robert, Patel Keyur, Borg Brian, Kabler Heidi, Poulos John, Younes Ziad H., Ruane Peter, Elkhashab Magdy, Hassanein Tarek, Iyer Rajalakshmi, Shiffman Mitchell, Strasser Simone, Wong Vincent Wai-Sun, Alkhouri Naim, LBO04 - Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial 73, p. S116 - S117 2020
Liver international Pockros Paul J., Fuchs Michael, Freilich Bradley, Schiff Eugene, Kohli Anita, Lawitz Eric J., Hellstern Paul A., MacConell Leigh, Owens-Grillo Janet, Van Biene Courtney, Shringarpure Reshma, Shapiro David, Cohen David E., CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients 39:11, p. 2082 - 2093 2019
Open forum infectious diseases Mera Jorge, Joshi Kartik, Thornton Karla, Box Terry, Scott John, Sedillo Miranda, Manch Richard, Deming Paulina, David Crystal, Essex Whitney, Kohli Anita, Retrospective Study Demonstrating High Rates of Sustained Virologic Response After Treatment With Direct-Acting Antivirals Among American Indian/Alaskan Natives 6:7, p. ofz128 - ofz128 2019
Hepatology communications Shrivastava Shikha, Bhatta Manasa, Ward Heley, Romani Sara, Lee Rebecca, Rosenthal Elana, Osinusi Anu, Kohli Anita, Masur Henry, Kottilil Shyam, Wilson Eleanor, Multitarget Direct-Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus 2:12, p. 1451 - 1466 2018
Journal of Viral Hepatitis Shrivastava S., Poonia B., Tang L., Osinusi A., Kohli Anita, Wilson E., Kottilil S., Augmentation of Hepatitis C Virus-Specific Immunity and Sustained Virologic Response 24:9, p. 742 - 749 2017
Hepatology communications Meissner Eric G., Kohli Anita, Higgins Jeanette, Lee Yu‐Jin, Prokunina Olga, Wu David, Orr Cody, Kottilil Shyam, Masur Henry, Rapid changes in peripheral lymphocyte concentrations during interferon‐free treatment of chronic hepatitis C virus infection 1:7, p. 586 - 594 2017
Scientific reports Nguyen Thi Huyen Tram, Guedj Jérémie, Uprichard Susan L, Kohli Anita, Kottilil Shyam, Perelson Alan S, , The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics? 7:1, p. 10233 - 10233 2017
Journal of acquired immune deficiency syndromes (1999) Wilson Eleanor, Lee Rebecca, Ward Haley, Howard Louisa, Rosenthal Elana, Shrivastava Shikha, Kohli Anita, Masur Henry, Kottilil Shyam, P-C8 Directly acting antiviral therapies have differential effects on cellular and soluble markers of inflammation in success-fully-treated HIV/HCV co-infected patients 74, p. 80 2017
Journal of acquired immune deficiency syndromes (1999) Rosenthal Elana, Bon Dimitra, Kattakuzhy Sarah, Tang Lydia, Hermann Eva, Kohli Anita, Kottilil Shyam, Wilson Eleanor, Masur Henry, P-C13 Impact of HIV status, HCV genotype, and number of DAAs on HCV viral kinetics in patients with HCV genotype 1 receiving DAA therapy 74, p. 82 2017
World journal of hepatology Tang Lydia Shuk Yee, Kottilil Shyam, Osinusi Anu, Kohli Anita, Kattakuzhy Sarah, Polis Michael, Nelson Amy, Masur Jack, Sims Zayani, Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment 8:31, p. 1318 - 1326 2016
Therapeutic advances in gastroenterology Kohli Anita, Alshati Ali, Georgie Fawaz, Manch Richard, Gish Robert G., Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney disease 9:6, p. 887 - 897 2016
Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America Kattakuzhy S., Gross C., Akoth E., McManus M., Emmanuel B., Shrivastava S., Tang L., . . . Kottilil, S., Kohli Anita, Wilson E., Price A., Sidharthan S., Sims Z., McLaughlin M., Silk R., Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease 62:4, p. 440 - 447 2016
Clinics in Liver Disease Joshi Kartik, Kohli Anita, Manch Richard, Gish Robert, Alcoholic Liver Disease: High Risk Or Low Risk for Developing Hepatocellular Carcinoma? 20:3, p. 563 - 580 2016
Hepatology international Thornton Karla, Deming Paulina, Manch Richard A, Moore Ann, Qualls Clifford, Scott John, Mera Jorge, Box Terry, Sedillo Miranda, Khaderi Saira, Arora Sanjeev, Kohli Anita, Gish Robert, Sussman Norman L, Is response guided therapy dead? Low cure rates in patients with detectable hepatitis C virus at week 4 of treatment 10:4, p. 624 - 631 2016
Journal of Viral Hepatitis Meissner E. G., Kohli Anita, Virtaneva K., Sturdevant D., Martens C., Porcella S. F., McHutchison J. G., Masur H., Kottilil S., Achieving Sustained Virologic Response After Interferon-Free Hepatitis C Virus Treatment Correlates with Hepatic Interferon Gene Expression Changes Independent of Cirrhosis 23:7, p. 496 - 505 2016
Gastroenterology (New York, N.Y. 1943) Ruane Peter J., Shiha Gamal, Abergel Armand, Asselah Tarik, Kohli Anita, Kottilil Shyam, Naggie Susanna, Doss Wahid, Esmat Gamal, Letterio Cathleen M., Kersey Kathryn, Hahambis Thomas A., Natha Macky, Kreter Bruce, Brainard Diana, Knox Steven, 756 Integrated Analysis of Sof+RBV or LDV/Sof for the Treatment of Genotype 4 Chronic HCV Infection 150:4, p. S1047 - S1048 2016
Gastroenterology (New York, N.Y. 1943) Flamm Steven, Modi Apurva A., Pungpapong Surakit, Leise Michael D., Aqel Bashar, Reddy K.R., Curry Michael, Brainard Diana, Llewellyn Joseph, Williams Laurie, Natha Macky, Kreter Bruce, Kohli Anita, Wyles David L., Lee Yoori, Su1423 Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/Sof) in Treatment-Experienced Cirrhotic Genotype 1 Patients With Chronic Hepatitis C (CHC): A Comparative Analysis of Gilead Sponsored Trials With 4 Real-World Cohorts (RWC) 150:4, p. S1095 - S1095 2016
AIDS Research and Human Retroviruses Townsend K., Meissner E. G., Sidharthan S., Sampson M., Remaley A. T., Tang L., Kohli Anita, Osinusi A., Masur H., Kottilil S., Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration 32:5, p. 456 - 462 2016
Hepatology International Petersen T., Townsend K., Gordon L. A., Sidharthan S., Osinusi A., Polis M. A., Masur H., Proschan M., Silk R., Kottilil S., Kohli Anita, Nelson A., Gross C., Calderon M., High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study 10:2, p. 310 - 319 2016
Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America Wilson E. M., Kattakuzhy S., Sidharthan S., Sims Z., Tang L., McLaughlin M., Price A., Nelson A., Silk R., Subramanian G. M., . . . Kottilil, S., Gross C., Akoth E., Mo H., Kohli Anita, Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens 62:3, p. 280 - 288 2016
Clinical Advances in Hematology & Oncology Kohli Anita, The Relationship between Hepatocellular Carcinoma and Hepatitis B and C Virus 14:2, p. 96 - 98 2016
Expert review of anti-infective therapy Nafisi Shirin, Roy Sabyasachi, Gish Robert, Manch Richard, Kohli Anita, Defining the possibilities: is short duration treatment of chronic hepatitis C genotype 1 with sofosbuvir-containing regimens likely to be as effective as current regimens? 14:1, p. 41 - 56 2016
Journal of acquired immune deficiency syndromes (1999) Kattakuzhy Sarah, Wilson Eleanor, Tang Lydia, Price Angie, Nelson Amy, Silk Rachel, Gross Chloe, Akoth Elizabeth, Kohli Anita, Osinusi Anu, Masur Henry, Kottilil Shyamasundaran, P-B4 Predictors of sustained viral response to 4–6 week duration therapy with Ledipasvir + Sofosbuvir + Gs-9451 +/− Gs-9669 in early and advanced fibrosis (Nih-Ihv synergy trial) 71:Supplement 1, p. 73 2016
Journal of acquired immune deficiency syndromes (1999) Wilson Eleanor, Mclaughlin Mary, Price Angie, Mo Hongmei, Osinusi Anu, Masur Henry, Kohli Anita, Kattakuzhy Sarah, Tang Lydia, Sims Zayani, P-B11 Retreatment of HCV GT-1 in patients who failed previous short course combination DAA therapy with 12 weeks of LDV/SOF is highly effective 71:Supplement 1, p. 77 2016
AIDS (London, England) Townsend K., Kohli Anita, Kottilil S., Nelson A., Seamon C., Gross C., Tang L., Osinusi A., Polis M. A., Petersen T., Gordon L. A., Masur H., Effect of HIV co-infection on adherence to a 12-week regimen of hepatitis C virus therapy with ledipasvir and sofosbuvir 30:2, p. 261 - 266 2016
Annals of internal medicine Kohli Anita, Sims Zayani, Silk Rachel, Gross Chloe, Akoth Elizabeth, Tang Lydia, Price Angie, Jolley Tim A., Emmanuel Benjamin, Proschan Michael, Osinusi Anuoluwapo, Teferi Gebeyehu, Chavez Jose, Abbott Stephen, Mo Hongmei, Polis Michael A., Wilson Eleanor, Masur Henry, Kottilil Shyam, McLaughlin Mary, Seamon Cassie, Meissner Eric G., Sidharthan Sreetha, Nelson Amy, Kattakuzhy Sarah, Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection 163:12, p. 899 2015
The American journal of gastroenterology Gill Kirat, Reynolds Justin, Kohli Anita, Moore Ann, Hepner Ashley, Gish Robert, Manch Richard, A Case of IgG4-Related Disease: A Unique Presentation of a Rare Entity 110, p. S109 - S110 2015
The American journal of gastroenterology Khosla Manraj, Dunatov Devin, Kohli Anita, Moore Ann, Hepner Ashley, Reynolds Justin, Manch Richard, Gish Robert, Recurrent Post-partum Jaundice: Rare Genetic Disorder With Novel Genetic Mutations Identified 110, p. S397 2015
The American journal of gastroenterology Gane Edward, Asselah Tarik, Kohli Anita, Mir Heshaam M., Natha Macky, Kersey Kathryn, Hyland Robert H., Pang Phil, McHutchison John G., Abergel Armand, Stedman Catherine A. M., Ledipasvir/Sofosbuvir With or Without Ribavirin for the Treatment of Patients With Genotype 2-6 Chronic HCV Infection: Summary Results From Four Phase II Studies 110, p. S870 - S871 2015
Open forum infectious diseases Hahn Katherine J., Kohli Anita, Sims Zayani, Kottilil Shyamasundaran, Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive Treatment 2:3, p. ofv091 - ofv091 2015
Clinical infectious diseases Sidharthan Sreetha, Kohli Anita, Kottilil Shyam, Hepatitis C Virus RNA Levels During Interferon-Free Combination Direct-Acting Antiviral Treatment in Registrational Trials Reply 61:4, p. 667 - 668 2015
The Lancet infectious diseases Kohli Anita, Pang Phillip S., Osinusi Anu, Polis Michael A., Sugarman Kate, Rustgi Vinod, Masur Henry, Kottilil Shyam, Kapoor Rama, Sims Zayani, Nelson Amy, Sidharthan Sreetha, Lam Brian, Silk Rachel, Kotb Colleen, Gross Chloe, Teferi Gebeyehu, Ledipasvir and Sofosbuvir for Hepatitis C Genotype 4: A Proof of Concept Phase 2a Cohort Study 15:9, p. 1049 - 1054 2015
Clinical infectious diseases Sidharthan Sreetha, Kohli Anita, Sims Zayani, Nelson Amy, Osinusi Anu, Masur Henry, Kottilil Shyam, Utility of hepatitis C viral load monitoring on direct-acting antiviral therapy 60:12, p. 1743 - 1751 2015
Journal of medical virology Kohli Anita, Burbelo Peter, Barrett Lisa, Meissner Eric G., Santich Brian, Shaffer Ashton, Johl Jessica, Sidharthan Sreetha, Moir Susan, Funk Emily, Kottilil Shyam, Fauci Anthony S., Persistently elevated abnormal B-cell subpopulations and anti-core antibodies in patients co-infected with HIV/HCV who relapse 87:4, p. 544 - 552 2015
JAMA : the journal of the American Medical Association Hogan John, Virologic response following combined ledipasvir and sofusbuvir administration in patients with HCV genotype 1 and HIV co-infection 313:12, p. 1232 2015
The Lancet (British edition) Kohli Anita, Petersen Tess, Townsend Kerry, Egerson D’Andrea, Kapoor Rama, Spurlin Emily, Teferi Gebeyehu, Kottilil Shyam, Subramanian G. Mani, Sneller Michael, Proschan Michael, Herrmann Eva, Kwan Richard, Osinusi Anuoluwapo, Sims Zayani, Nelson Amy, Meissner Eric G., Barrett Lisa L., Bon Dimitra, Marti Miriam M, Silk Rachel, Kotb Colleen, Gross Chloe, Jolley Tim A, Sidharthan Sreetha, Abbott Stephen, Talwani Rohit, Diaz Gabbie, Kleiner David E., Wood Brad J., Chavez Jose, Fauci Anthony S, Masur Henry, McHutchison John, Polis Michael A., Pang Phillip S., Symonds William T., Directly Acting Triple Drug Anti-HCV Therapy Induces Sustained Virologic Response with a Six Week Regimen: A Proof of Concept Phase 2a Cohort Study 385:9973, p. 1107 - 1113 2015
JAMA : the journal of the American Medical Association Kohli Anita, Kottilil Shyam, Assessment of outcomes of hepatitis C treatment--reply 312:23, p. 2571 - 2571 2014
Open forum infectious diseases Meissner Eric, Kohli Anita, Nelson Amy, Sims Zayani, Mchutchison John G., Masur Henry, Kottilil Shyam, LB-4Changes in Intrahepatic, Endogenous Interferon Expression in Chronic HCV, Genotype-1 Patients Treated with Interferon-free, Ribavirin-Free DAA Regimens 1:suppl_1, p. S67 - S67 2014
Annals of internal medicine Osinusi Anu, Pang Phillip S., Subramanian G. Mani, McHutchison John G., Meissner Eric G., Silk Rachel, Townsend Kerry, Kohli Anita, Marti Miriam M., Nelson Amy, Zhang Xiaozhen, Fauci Anthony S., Masur Henry, Kottilil Shyam, Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse An Open-Label Pilot Study 161:9, p. 634 - U126 2014
SpringerPlus Kohli Anita, Murphy Allison A, Agarwal Chirdeep, Shivakumar Bhavana, Kottilil Shyam, Polis Michael A, Desai Srinivas, Subramanian G Mani, Midha Vandana, Goyal Omesh, Sood Ajit, Shah Samir, HCC surveillance results in earlier HCC detection: results from an Indian cohort 3:1, p. 1 - 5 2014
JAMA : the journal of the American Medical Association Kohli Anita, Kottilil Shyam, Sherman Amy, Shaffer Ashton, Treatment of Hepatitis C A Systematic Review 312:6, p. 631 - 640 2014
AIDS research and human retroviruses Shaffer Ashton, Hubbard Jon J., Townsend Kerry, Kottilil Shyam, Polis Michael A., Masur Henry, Kohli Anita, Short Communication: Serum-Based Assay Accurately Detects Single Nucleotide Polymorphisms of IL28B and SOCS3 in HIV/Hepatitis C Virus-Coinfected Subjects 30:8, p. 792 - 795 2014
AIDS research and human retroviruses Funk Emily K., Shaffer Ashton, Shivakumar Bhavana, Sneller Michael, Nelson Amy, Kwan Richard, Kottilil Shyam, Kohli Anita, Heytens Laura, Polis Michael A., Masur Henry, Short Communication: Interferon/Ribavirin Treatment for HCV Is Associated with the Development of Hypophosphatemia in HIV/Hepatitis C Virus-Coinfected Patients 29:9, p. 1190 - 1194 2013
JAMA : the journal of the American Medical Association Osinusi Anuoluwapo, Nelson Amy, Sneller Michael, Kwan Richard, Teferi Geb, Talwani Rohit, Meissner Eric G., Heytens Laura, Herrmann Eva, Shivakumar Bhavana, Gu Wenjuan, Lee Yu-Jin, Bon Dimitra, Wroblewski Susan, Kohli Anita, Barrett Lisa, Proschan Michael, Silk Rachel, Kotb Colleen, Fishbein Dawn, Kleiner David, Dewar Robin, Highbarger Helene, Zhang Xiao, Wood Brad J., McHutchison John, Chavez Jose, Symonds William T., Subramanian Mani, Polis Michael A., Fauci Anthony S., Masur Henry, Kottilil Shyamasundaran, Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics A Randomized Clinical Trial 310:8, p. 804 - 811 2013
AIDS research and human retroviruses Sherman Amy C., Trehanpati Nirupama, Daucher Marybeth, Davey Richard T., Masur Henry, Sarin Shiv Kumar, Kottilil Shyam, Kohli Anita, Augmentation of Hepatitis B Virus-Specific Cellular Immunity with Programmed Death Receptor-1/Programmed Death Receptor-L1 Blockade in Hepatitis B Virus and HIV/Hepatitis B Virus Coinfected Patients Treated with Adefovir 29:4, p. 665 - 672 2013
Journal of acquired immune deficiency syndromes (1999) Sidique Nadeera, Polis Michael A., Masur Henry, Kottilil Shyam, Kohli Anita, Shivakumar Bhavana, Migueles Stephen, Subramanian G. Mani, Naggie Susanna, HIV/HCV-Coinfected Natural Viral Suppressors Have Better Virologic Responses to PEG-IFN and Ribavirin Than ARV-Treated HIV/HCV Patients 58:2, p. E38 - E40 2011
The American journal of tropical medicine and hygiene Houpt Eric R, Bushen Oluma Y, Shao John F, Sam Noel E, Kohli Anita, Asgharpour Amon, NG Cherie T, Calfee David P, Guerrant Richard L, Maro Venance, OLE-NGUYAINE Sendui, Short report : Asymptomatic Cryptosporidium hominis infection among human immundeficiency virus-infected patients in tanzania 73:3, p. 520 - 522 2005